• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

When neurons turn against themselves

Bioengineer by Bioengineer
August 30, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Doron Merkler / UNIGE

Rasmussen's encephalitis is a rare autoimmune disease that primarily affects children and can lead to seizures. As the disease is resistant to drug treatments, it frequently requires surgical interventions aiming to remove or disconnect the affected part of the brain. Researchers from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have succeeded in describing and mastering the mechanisms at work within neurons in mice, opening the way to possible treatments. It was previously thought that neurons were the target of immune system cells that attack synapses, the connections between neurons. But researchers have discovered that the neurons themselves play an active role in triggering this process. Their research is published by Cell.

In Rasmussen encephalitis, like in other encephalitis, the presence of an antigen in the affected neurons triggers an immune system response, resulting in synaptic alterations. A team of researchers led by Doron Merkler, Associate Professor in the Department of Pathology and Immunology at the UNIGE Faculty of Medicine and senior consultant in the Clinical Pathology Service of the HUG, was able to show that neurons are not only passive victims of this attack, but play an essential role in triggering a defence mechanism that ultimately leads to their own damage. &laquoFollowing the attack by CD8+ T lymphocytes of the immune system, which fight against viral infections, the neuron produces a chemical signal to other cells called phagocytes which then attack the synapses. It's a sort of tripartite tango with tragic consequences,» explains Doron Merkler.

A double attack on the synapses

Triggered by the neuronal antigen, CD8+ T lymphocytes release a protein, IFN-γ, captured by corresponding neuronal receptor. Subsequently neurons activate the STAT 1 signalling pathway which leads to the production of a molecule called CCL2. The latter molecule diffuses into the neuronal environment where it activates other immune cell types called phagocytes: these are microglial cells present in the brain and macrophages derived from the blood circulation. These two types of phagocytes finally attack the synapses. &laquoIf we manage to cut off the signal emitted by the neuron, this whole cascade of causes and consequences could be blocked,» stresses Giovanni Di Liberto, researcher in the Department of Pathology and Immunology at the UNIGE Faculty of Medicine and first author of the study.

A similar signalling signature could also be found in biopsies performed in more than 20 patients suffering from Rasmussen encephalitis, and researchers advocate that it is possibly identical for other forms of encephalitis. In mice experiments, this mechanism has been successfully blocked at different levels: The UNIGE and HUG teams have thus succeeded in blocking the signalling pathway of STAT1 and CCL2 molecules, as well as the migration and activation of phagocytes by pharmacological interventions and genetic manipulation, avoiding in all these cases the degradation of synapses and allowing for a better control of the disease.

Researchers will now have to partner to pursue the development of a possible treatment and conduct the necessary clinical trials, a difficult task when it comes to rare diseases. &laquoBut the principles we are describing are probably at work in other diseases that cause a strong immune response, and may even play a role in multiple sclerosis,» says Merkler.

###

Media Contact

Doron Merkler
[email protected]
41-223-724-943
@UNIGEnews

http://www.unige.ch

Original Source

https://www.unige.ch/communication/communiques/en/2018/quand-les-neurones-se-retournent-contre-eux-memes/ http://dx.doi.org/10.1016/j.cell.2018.07.049

Share12Tweet8Share2ShareShareShare2

Related Posts

Risk Assessment Models Reduce Venous Thromboembolism Prophylaxis

November 4, 2025

Pneumonia Prevalence in Under-Five Children in Jigjiga

November 4, 2025

Mutations Disrupt Transcription Factors in Fertilization Failure

November 4, 2025

Successful Live Birth from Tripronuclear Zygote Enucleation

November 4, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1298 shares
    Share 518 Tweet 324
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    205 shares
    Share 82 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Risk Assessment Models Reduce Venous Thromboembolism Prophylaxis

Unveiling Wheat’s Defense Against WSMV: A Transcriptomic Study

Unveiling Wheat’s Defense Against WSMV: A Transcriptomic Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.